샘플 요청 목록

 카트 문의
시장보고서
상품코드
1564053

세계의 개 줄기세포 치료 시장

Canine Stem Cell Therapy
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 197 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 개 줄기세포 치료 시장은 2030년까지 2억 5,380만 달러에 달할 전망

2023년에 2억 10만 달러로 평가된 세계의 개 줄기세포 치료 시장은 2030년에는 2억 5,380만 달러에 이를 전망이며, 분석 기간 2023년부터 2030년까지 CAGR은 3.5%로 성장할 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 동종 줄기세포는 CAGR 3.9%로 성장을 지속하고, 분석 기간 종료시에는 1억 7,480만 달러에 달할 것으로 예측됩니다. 자가 줄기세포 부문의 성장률은 분석 기간 동안 CAGR 2.5%로 추정됩니다.

미국 시장은 5,290만 달러로 추정되는 반면, 중국은 CAGR 3.3%로 성장할 것으로 예측

미국의 개 줄기세포 치료 시장은 2023년 5,290만 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 4,060만 달러 규모에 이를 것으로 예측되며, 분석 기간 2023년부터 2030년까지 CAGR은 3.3%로 전망됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.3%와 2.8%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 3.4%로 성장할 것으로 예측됩니다.

세계의 개 줄기세포 치료 시장-주요 동향 및 촉진요인 요약

개 줄기세포 치료가 동물의료로 인기를 모으는 이유란?

개 줄기세포 치료는 동물 의료에서 획기적인 치료법으로 급속히 보급되고 있으며, 특히 개 변성 질환, 부상, 면역 질환 등, 한때는 관리가 어려웠던 증상에 희망을 가져왔습니다. 줄기 세포, 특히 개 자신의 지방 조직 유래 줄기 세포(지방 유래 줄기 세포)는 손상된 조직을 재생하고 염증을 억제하고 전반적인 치유를 촉진하는 독특한 능력을 가지고 있습니다. 이 치료법은 골관절염, 고관절 형성 부전, 인대 손상과 같은 근골격계 질환의 치료에 가장 일반적으로 사용됩니다. 이러한 질병에 대한 전통적인 치료법, 예를 들어 비 스테로이드 성 항염증제(NSAIDs), 물리치료 또는 외과적 수술은 일시적인 완화를 초래하지만 부작용과 합병증의 위험이 수반됩니다. 대조적으로, 줄기세포 치료는 침습성이 낮은 솔루션을 제공하며 장기적인 효과를 기대할 수 있습니다. 줄기세포 치료는 신체의 자연 치유 과정을 이용하여 개 운동 능력과 삶의 질에 영향을 미치는 증상을 치료하는 보다 종합적인 접근법입니다. 더 많은 수의사와 주인이 이점을 인식함에 따라, 개 줄기세포 치료에 대한 수요가 증가하고 있으며, 동물 의료에서 고급 재생 치료로의 광범위한 변화를 반영합니다.

기술은 어떻게 개 줄기세포 치료를 진화시키고 있는가?

개 줄기세포 치료의 성공과 그 확산은 생명 공학과 재생 의료의 급속한 진보와 밀접하게 관련되어 있습니다. 지난 10년 동안 줄기세포의 가공과 투여 방법에 큰 진보가 있었고, 수의사와 주인 모두에게 이러한 치료의 안전성, 효능 및 편리성이 향상되었습니다. 지방 유래 줄기세포를 채취하고 처리하는 방법이 개선되어 줄기세포의 추출, 정제, 확대가 전문 연구실에서 보다 빠르고 정확하게 할 수 있게 된 것도 큰 진보의 하나입니다. 줄기세포의 질과 생존율이 치료의 가능성에 직접 영향을 주기 때문입니다. 게다가, 특히 환자로부터 줄기세포를 채취하는 것이 곤란한 경우에, 기증자가 되는 동물 유래의 동종 줄기세포를 사용하는 것도 새로운 동향이 되고 있습니다. 이 접근법은 치료의 폭을 넓히고 자가 줄기세포 채취가 어려운 기초 질환을 가진 개에게도 해결책을 제공합니다. 채취한 줄기세포를 장기 보존해, 몇번이나 수술하지 않고 장래의 치료에 재이용하는 것을 가능하게 하는 동결보존 기술도 큰 진보입니다. 이와 같은 기술 혁신에 더해 MRI나 초음파와 같은 촬상기술을 이용함으로써 줄기세포 주입의 표적을 정확하게 정할 수 있게 되어 줄기세포 치료는 보다 친숙해질 뿐만 아니라, 복잡하고 만성 질환에 더 효과적인 것이 되었습니다.

어떤 동향 및 과제가 개 줄기세포 치료 시장을 형성하고 있는가?

개 줄기세포 치료 시장의 급성장과 진화를 형성하는 주요 동향은 몇 가지 있지만, 그 큰 촉진요인이 되는 것은 반려동물에 대한 비침습적인 재생 치료에 대한 수요 증가입니다. 반려동물 주인이 고급 수의학적 치료 옵션에 대한 지식을 높이면서 기존의 치료에 비해 부작용이 적을수록 더 나은 결과를 얻을 수 있는 치료법에 대한 선호도가 높아지고 있습니다. 이 동향은 반려동물 관리 산업에서 합리적이고 통합적인 치료에 대한 광범위한 움직임과 일치하며, 단순히 증상을 관리하는 것이 아니라 전반적인 건강을 촉진하고 증상의 근본 원인으로 해결에 중점을 둡니다. 또한, 변형성 관절증 등의 퇴행성 관절 질환의 치료에 줄기세포 치료가 유효하다는 것을 뒷받침하는 연구나 임상적 근거의 확산은 수의사들 사이에서 줄기세포 치료의 신뢰성을 높여 그 채용을 더욱 밀어주고 있습니다. 그러나 이러한 긍정적인 추세에도 불구하고 시장은 몇 가지 문제에 직면하고 있습니다. 주요 장애물 중 하나는 치료 비용이며 많은 주인에게는 여전히 고액이므로이 고급 치료에 대한 액세스가 제한 될 수 있습니다. 또한 줄기세포 제품의 일관성과 품질을 보장하기 위해 규제 당국의 모니터링이 필요합니다. 게다가 줄기세포 치료는 다양한 질환의 치료에 유망시되고 있지만, 그 가능성과 한계를 충분히 이해하기 위해서는 아직 장기적인 연구가 필요합니다. 이러한 과제에도 불구하고, 이 분야에서 성공 사례 증가와 현재 진행 중인 기술 혁신은 개 줄기세포 치료의 미래가 밝다는 것을 시사합니다.

개 줄기세포 치료 시장의 성장을 가속하는 요인이란?

개 줄기세포 치료 시장의 성장은 수의학의 진보, 재생 의학에 대한 인식 증가, 노인 개와 부상을 입은 개에 대한 저침습 치료 옵션에 대한 수요 증가와 같은 몇 가지 요인에 의해 야기됩니다. 특히 헬스케어의 향상으로 반려동물의 수명이 연장됨에 따라 골관절염, 고관절 형성부전, 인대 손상 등의 만성 질환의 유병률이 증가하고 있는 것이 이 성장의 주요 요인입니다. 개 수명이 연장됨에 따라 침습적인 수술이나 장기 투약에 의존하지 않고 QOL(생활의 질)을 향상시키는 치료가 필요해지고 있습니다. 줄기세포 치료는 실행 가능한 솔루션을 제공하여 운동 능력을 크게 향상시키고 통증을 줄이는 재생 효과를 제공합니다. 게다가 동결보존이나 동종 줄기세포의 사용 등 줄기세포의 처리와 보존의 진보에 의해 보다 폭넓은 수의료 현장이 줄기세포 치료를 이용할 수 있게 되어, 그 보급을 한층 더 뒷받침하고 있습니다. 반려동물의 주인이 줄기세포 치료의 잠재적인 효과에 대한 지식을 깊게 하고, 종래의 치료를 대체하는 치료법을 반려동물에게 요구하게 된 것도 소비자 행동에 큰 영향을 미치고 있습니다. 동물병원에서 줄기세포 치료의 보급과 생명공학 기업과 동물병원의 제휴는 줄기세포 치료의 상업화와 주류화를 뒷받침하고 있습니다. 또한 개별 반려동물의 필요에 맞게 치료를 수행하는 맞춤형 의료에 대한 관심이 증가하고 있으며, 줄기세포 치료가 다양한 질병 치료에 고도로 맞춤화된 접근법을 제공하기 때문에 시장은 계속 확대하고 있습니다. 생명공학의 지속적인 발전과 소비자의 관심이 높아짐에 따라, 개 줄기세포 치료 시장은 앞으로도 지속적인 성장이 예상됩니다.

조사 대상 기업 예(전 47건)

  • Animal Cell Therapies, Inc
  • Aratana Therapeutics, Inc.
  • Cell Therapy Sciences
  • Magellan Stem Cells
  • MediVet Biologics, LLC
  • Okyanos
  • Regeneus Ltd.
  • Stem Cell Vet
  • Vetbiologics
  • VetMatrix

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

AJY 24.10.11

Global Canine Stem Cell Therapy Market to Reach US$253.8 Million by 2030

The global market for Canine Stem Cell Therapy estimated at US$200.1 Million in the year 2023, is expected to reach US$253.8 Million by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Allogeneic Stem Cells, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$174.8 Million by the end of the analysis period. Growth in the Autologous Stem Cells segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$52.9 Million While China is Forecast to Grow at 3.3% CAGR

The Canine Stem Cell Therapy market in the U.S. is estimated at US$52.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$40.6 Million by the year 2030 trailing a CAGR of 3.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Canine Stem Cell Therapy Market - Key Trends and Drivers Summarized

Why Is Canine Stem Cell Therapy Gaining Popularity in Veterinary Medicine?

Canine stem cell therapy has rapidly gained traction as a revolutionary treatment in veterinary medicine, offering hope for conditions that were once difficult to manage in dogs, particularly degenerative diseases, injuries, and immune disorders. Stem cells, especially those derived from a dog's own fat tissue (adipose-derived stem cells), have the unique ability to regenerate damaged tissues, reduce inflammation, and promote overall healing. This therapy is most commonly used to treat musculoskeletal conditions like osteoarthritis, hip dysplasia, and ligament injuries—ailments that cause significant pain and limited mobility in dogs, particularly as they age. Traditional treatments for these conditions, such as non-steroidal anti-inflammatory drugs (NSAIDs), physical therapy, or even surgical interventions, can offer temporary relief but often come with side effects or the risk of complications. Stem cell therapy, by contrast, offers a less invasive solution with the potential for longer-lasting results. It works by harnessing the body’s natural healing processes, making it a more holistic approach to treating conditions that affect a dog’s mobility and quality of life. As more veterinarians and pet owners recognize its benefits, the demand for canine stem cell therapy has grown, reflecting a broader shift toward advanced regenerative therapies in animal care.

How Is Technology Advancing Canine Stem Cell Therapy?

The success and expanding reach of canine stem cell therapy are closely tied to rapid advancements in biotechnology and regenerative medicine. Over the past decade, significant progress has been made in how stem cells are processed and administered, improving the safety, efficacy, and convenience of these treatments for both veterinarians and pet owners. One major development is the refinement of methods for harvesting and processing adipose-derived stem cells, where stem cells can now be extracted, purified, and expanded in specialized laboratories with greater speed and precision. This allows for quicker treatment cycles and improved outcomes, as the quality and viability of the stem cells have a direct impact on their therapeutic potential. Additionally, the use of allogeneic stem cells, which are derived from donor animals, is an emerging trend, particularly for cases where it may not be feasible to collect stem cells from the patient. This approach broadens the availability of treatments, offering a solution even for dogs with underlying conditions that complicate autologous stem cell collection. Another significant advancement is in cryopreservation techniques, which allow harvested stem cells to be stored long-term and reused in future treatments without requiring repeated surgeries. These technological innovations, combined with the use of imaging technologies like MRI and ultrasound for precise targeting of stem cell injections, have made stem cell therapy not only more accessible but also more effective at addressing complex and chronic conditions.

What Trends and Challenges Are Shaping the Canine Stem Cell Therapy Market?

Several key trends are shaping the rapid growth and evolution of the canine stem cell therapy market, driven largely by the increasing demand for non-invasive, regenerative treatments for pets. As pet owners become more informed about advanced veterinary care options, there is a growing preference for therapies that can deliver better outcomes with fewer side effects compared to conventional treatments. This trend aligns with a broader movement in the pet care industry toward holistic and integrative treatments, where the focus is on promoting overall wellness and addressing the root causes of conditions rather than just managing symptoms. Moreover, the expanding research and clinical evidence supporting the efficacy of stem cell therapy in treating degenerative joint diseases, such as osteoarthritis, has bolstered its credibility among veterinarians, further encouraging its adoption. However, despite these positive trends, the market faces several challenges. One of the main hurdles is the cost of treatment, which remains high for many pet owners, potentially limiting access to this advanced therapy. There is also a need for more regulatory oversight to ensure the consistency and quality of stem cell products, as variations in how stem cells are processed can impact their safety and effectiveness. Moreover, while stem cell therapy has shown promise in treating a variety of conditions, long-term studies are still needed to fully understand its potential and limitations. Despite these challenges, the increasing number of success stories and ongoing innovations in the field suggest that the future of canine stem cell therapy is bright.

What Factors Are Propelling Growth in the Canine Stem Cell Therapy Market?

The growth in the canine stem cell therapy market is driven by several factors, including advancements in veterinary science, increased awareness of regenerative medicine, and the rising demand for minimally invasive treatment options for aging and injured dogs. A key driver of this growth is the increasing prevalence of chronic conditions such as osteoarthritis, hip dysplasia, and ligament injuries in dogs, particularly as pet lifespans increase due to improved healthcare. As dogs live longer, the need for treatments that can enhance their quality of life without relying on invasive surgery or long-term medications becomes more critical. Stem cell therapy provides a viable solution, offering regenerative benefits that can significantly improve mobility and reduce pain. Additionally, advancements in the processing and storage of stem cells, including cryopreservation and the use of allogeneic stem cells, have made the therapy more accessible to a wider range of veterinary practices, further driving its adoption. Consumer behavior also plays a significant role, as pet owners become more educated about the potential benefits of stem cell therapy and seek alternatives to traditional treatments for their pets. The increasing availability of stem cell therapy at veterinary clinics, coupled with partnerships between biotech companies and veterinary practices, is helping to commercialize the therapy and make it more mainstream. Furthermore, the rising interest in personalized veterinary care, where treatments are tailored to the specific needs of individual pets, continues to propel the market, as stem cell therapy offers a highly customizable approach to treating a wide range of conditions. With ongoing advancements in biotechnology and growing consumer interest, the canine stem cell therapy market is poised for sustained growth in the coming years.

Select Competitors (Total 47 Featured) -

  • Animal Cell Therapies, Inc
  • Aratana Therapeutics, Inc.
  • Cell Therapy Sciences
  • Magellan Stem Cells
  • MediVet Biologics, LLC
  • Okyanos
  • Regeneus Ltd.
  • Stem Cell Vet
  • Vetbiologics
  • VetMatrix

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Canine Stem Cell Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Canine Osteoarthritis Throws the Spotlight on Stem Cell Therapy as a Key Treatment Option
    • Here's How Advancements in Regenerative Medicine Drive Adoption of Canine Stem Cell Therapy
    • Growing Demand for Minimally Invasive Treatments Spurs Growth in Stem Cell Therapy for Pets
    • Increasing Pet Ownership and Spending on Pet Healthcare Expands Addressable Market Opportunity for Stem Cell Therapies
    • Here's the Story: Improved Stem Cell Isolation Techniques Propel Growth in Treatment Efficacy
    • Advances in Cryopreservation Technologies Generate New Opportunities for Repeat Stem Cell Treatments
    • Growing Interest in Alternative Therapies for Pain Management Propels Adoption of Stem Cell Treatments
    • Research on Stem Cell Applications for Immune and Neurological Disorders Expands Treatment Horizons
    • Increased Availability of Stem Cell Therapies in Specialty Veterinary Clinics Drives Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Canine Stem Cell Therapy Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Canine Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Canine Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Autologous Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Autologous Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Autologous Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Veterinary Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Veterinary Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Veterinary Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Veterinary Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Veterinary Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Veterinary Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Veterinary Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Veterinary Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Veterinary Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • JAPAN
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • CHINA
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • EUROPE
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Canine Stem Cell Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Canine Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • FRANCE
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • GERMANY
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제